Drug details

ATNAA (atropine and pralidoxime chloride injection)

type of Anticholinergic Agents

ATNAA (atropine and pralidoxime chloride injection) is a combination of a cholinergic muscarinic antagonist and a cholinesterase reactivator used to treat poisoning by susceptible organophosphorus nerve agents having anticholinesterase activity in adults.

This drug may have the following side effects:

• nausea,
• rash,
• vomiting,
• confusion,
• dry mouth,
• headache,
• drowsiness,
• increased blood pressure,
• fast heart rate,
• blurred vision/changes in vision,
• dry eyes,
• sensitivity to light (photophobia),
• dizziness
• muscular weakness,
• dry skin,
• hyperventilation,
• decreased kidney (renal) function,
• excitement,
• manic behavior, and
• temporary elevation of liver enzymes and creatine phosphokinase